1
Views
0
CrossRef citations to date
0
Altmetric
ARRHYTHMIAS AND CHF

Arrhythmias in patients with CHF

Should they be treated?

Pages 50-61 | Published online: 07 Jul 2016

References

  • Swedberg K, Kjekshus J. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). Am J Cardiol 1988: 62(2): 60–6A
  • Massie BM, Conway M,. Survival of patients with congestive heart failure: past, present, and future prospects. Circulation 1987: 75(5 Pt 2): IV 11–9
  • Fletcher RD, Archibald D, Omdorff J, et al. Dysrhythmias on short term holter as an independent predictor of mortality in congestive heart failure. (Abstr) J Am Coll Cardiol 1986: 7: 143A
  • Szlachcic J, Massie BM, Kramer BL, et al. Correlates and prognostic implication of exercise capacity in chronic congestive heart failure. Am J Cardiol 1985: 55(8): 1037–42
  • Franciosa JA. Why patients with heart failure die: hemodynamic and functional determinants of survival. Circulation 1987: 75(5 Pt 2): IV 20–7
  • Bigger JT Jr. Why patients with congestive heart failure die: arrhythmias and sudden cardiac death. Circulation 1987: 75(5 Pt 2): IV 28–35
  • Bigger JT Jr, Weld FM, Rolnitzky LM. Prevalence, characteristics and significance of ventricular tachycardia (three or more complexes) detected with ambulatory electrocardiographic recording in the late hospital phase of acute myocardial infarction. Am J Cardiol 1981: 48(5): 815–23
  • Szentpetery S, Hanrahan J, Richardson J, et al. Spectrum of ventricular arrhythmias in patients undergoing cardiac transplantation. (Abstr) PACE 1988: 11: 935
  • Gomes JA, Hariman RI, Kang PS, et al. Programmed electrical stimulation in patients with high-grade ventricular ectopy: electrophysiologic findings and prognosis for survival. Circulation 1984: 70(1): 43–51
  • Milner PG, Dimarco JP, Lerman BB. Electrophysiological evaluation of sustained ventricular tachyarrhythmias in idiopathic dilated cardiomyopathy. PACE 1988: 11(5): 562–8
  • Naccarelli GV, Prystowsky EN, Jackman WM, et al. Role of electrophysiologic testing in managing patients who have ventricular tachycardia unrelated to coronary artery disease. Am J Cardiol 1982: 50(1): 165–71
  • Meinertz T, Treese N, Kasper W, et al. Determinants of prognosis in idiopathic dilated cardiomyopathy as determined by programmed electrical stimulation. Am J Cardiol 1985: 56(4): 337–41
  • Chakko CS, Gheorghiade M. Ventricular arrhythmias in severe heart failure: incidence, significance, and effectiveness of antiarrhythmic therapy. Am Heart J 1985: 109(3 Pt 1): 497–504
  • Parmley WW, Chatterjee K. Congestive heart failure and arrhythmias: an overview. Am J Cardiol 1986: 57(3): 34–7B
  • Dargie HJ, Cleland JG, Leckie BJ, et al. Relation of arrhythmias and electrolyte abnormalities to survival in patients with severe chronic heart failure. Circulation 1987: 75(5 Pt 2): IV 98–107
  • Gottdiener JS, DiBianco R, Fletcher RD. Effects of antiarrhythmic agents on cardiac function. Angiology 1982: 33(4): 228–38
  • Podrid PJ, Schoeneberger A, Lown B. Congestive heart failure caused by oral disopyramide. N Engl J Med 1980: 302(11): 614–7
  • Woosley RL, Echt DS, Roden DM. Effects of congestive heart failure on the pharmacokinetics and pharmacodynamics of antiarrhythmic agents. Am J Cardiol 1986: 57(3): 25–33B
  • Morganroth J, Horowitz LN. Incidence of proarrhythmic effects from quinidine in the outpatient treatment of benign or potentially lethal ventricular arrhythmias. Am J Cardiol 1985: 56(10): 585–7
  • Sami MH, Derbekyan VA, Lisbona R. Hemodynamic effects of encainide in patients with ventricular arrhythmia and poor ventricular function. Am J Cardiol 1983: 52(5): 507–11
  • Josephson MA, Kaul S, Hopkins J, et al. Hemodynamic effects of intravenous flecainide relative to the level of ventricular function in patients with coronary artery disease. Am Heart J 1985: 109(1): 41–5
  • Morganroth J. Risk factors for the development of proarrhythmic events. Am J Cardiol 1987: 59(11): 32–7E
  • de Paola AA, Horowitz LN, Morganroth J, et al. Influence of left ventricular dysfunction on flecainide therapy. J Am Coll Cardiol 1987: 9(1): 163–8
  • Soyka LF. Safety of encainide for the treatment of ventricular arrhythmias. Am J Cardiol 1986: 58(5): 96–103C
  • Mason JW. Amiodarone. N Engl J Med 1987: 316(8): 455–66
  • Ellenbogen KA, O'Callaghan WG, Colavita PG, et al. Cardiac function in patients on chronic amiodarone therapy. Am Heart J 1985: 110(2): 376–81
  • Cleland JG, Daigie HJ, Findlay IN, et al. Clinical, haemodynamic, and antiarrhythmic effects of lone term treatment with amiodarone of patients in heart failure. Br Heart J 1987: 57(5): 436–45
  • De Paola AA, Horowitz LN, Spielman SR, et al. Development of congestive heart failure and alterations in left ventricular function in patients with sustained ventricular tachyarrhythmias treated with amiodarone. Am J Cardiol 1987: 60(4): 276–80
  • Sheldon RS, Mitchell LB, Duff NJ, et al. Effect of amiodarone therapy on ventricular function: serial, long-term assessment. (Abstr) J Am Coll Cardiol 1988: 11: 91A
  • Herre JM, Sauve MJ, Malone P, et al. Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation. J Am Coll Cardiol 1989: 13: 442–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.